Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
4.22
-0.04 (-0.94%)
At close: Aug 15, 2025, 10:04 AM
-0.94% (1D)
| Bid | 4.21 |
| Market Cap | 349.32M |
| Revenue (ttm) | 241K |
| Net Income (ttm) | -95.23M |
| EPS (ttm) | -1.51 |
| PE Ratio (ttm) | -2.79 |
| Forward PE | -1.94 |
| Analyst | Buy |
| Ask | 4.23 |
| Volume | 461,223 |
| Avg. Volume (20D) | 1,349,182 |
| Open | 4.32 |
| Previous Close | 4.26 |
| Day's Range | 4.20 - 4.41 |
| 52-Week Range | 1.61 - 9.50 |
| Beta | 0.94 |
About LRMR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LRMR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LRMR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-3.02%
Larimar Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
8 months ago
-21.72%
Larimar Therapeutics shares are trading lower after the company reported initial data from its ongoing OLE rare disease drug study.
